PL2613777T3 - Kompozycje zawierające kwasowe ekstrakty mastyksu - Google Patents

Kompozycje zawierające kwasowe ekstrakty mastyksu

Info

Publication number: PL2613777T3
Authority: PL; Poland
Prior art keywords: compositions; mastic gum; acidic extracts; acidic; extracts
Prior art date: 2010-09-07

Application number

PL11823157T

Other languages

English (en)

Inventor

Zadik Hazan

Andre C B Lucassen

Original Assignee

Regenera Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-09-07

Filing date

2011-09-07

Publication date

2019-10-31

2011-09-07 Application filed by Regenera Pharma Ltd filed Critical Regenera Pharma Ltd

2019-10-31 Publication of PL2613777T3 publication Critical patent/PL2613777T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Natural Medicines & Medicinal Plants (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Alternative & Traditional Medicine (AREA)
Mycology (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Immunology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Nutrition Science (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)

PL11823157T 2010-09-07 2011-09-07 Kompozycje zawierające kwasowe ekstrakty mastyksu PL2613777T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US38033910P	2010-09-07	2010-09-07
EP11823157.0A EP2613777B1 (en)	2010-09-07	2011-09-07	Compositions comprising acidic extracts of mastic gum
PCT/IL2011/000724 WO2012032523A2 (en)	2010-09-07	2011-09-07	Compositions comprising acidic extracts of mastic gum

Publications (1)

Publication Number	Publication Date
PL2613777T3 true PL2613777T3 (pl)	2019-10-31

Family

ID=45811024

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL11823157T PL2613777T3 (pl)	2010-09-07	2011-09-07	Kompozycje zawierające kwasowe ekstrakty mastyksu

Country Status (13)

Country	Link
US (4)	US9271949B2 (pl)
EP (2)	EP2613777B1 (pl)
JP (3)	JP5876052B2 (pl)
KR (2)	KR101910781B1 (pl)
CN (2)	CN106924266A (pl)
AU (1)	AU2011300359B2 (pl)
BR (2)	BR112013005300B1 (pl)
CA (1)	CA2810472A1 (pl)
DK (1)	DK2613777T3 (pl)
ES (1)	ES2732559T3 (pl)
IL (2)	IL225004B (pl)
PL (1)	PL2613777T3 (pl)
WO (1)	WO2012032523A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2810472A1 (en) *	2010-09-07	2012-03-15	Regenera Pharma Ltd.	Compositions comprising acidic extracts of mastic gum
IL237621A0 (en) *	2015-03-08	2015-06-30	Regenera Pharma Ltd	Use of isolated fractions of the gum goddess to treat optic neuropathy
CA2999820A1 (en)	2015-09-24	2017-03-30	Regenera Pharma Ltd.	Compositions comprising triterpenoids
DK3352742T3 (da)	2015-09-24	2022-01-10	Regenera Pharma Ltd	Præparater omfattende triterpenoider til behandling af Alzheimers sygdom og Parkinsons sygdom
CN106178068B (zh) *	2016-08-18	2017-09-19	广州华弘生物科技有限公司	一种促进伤口愈合的贴膜及缝合器
KR20190049757A (ko) *	2016-09-08	2019-05-09	레제네라 파마 리미티드	매스틱 검(mastic gum)의 산성 추출물을 포함하는 조성물 및 시신경병증 치료를 위한 이의 용도
KR20190050800A (ko)	2016-09-08	2019-05-13	레제네라 파마 리미티드	트리테르페노이드를 포함하는 조성물 및 시신경병증을 치료하기 위한 이의 용도
FR3057467B1 (fr) *	2016-10-17	2018-12-07	IFP Energies Nouvelles	Procede de purification d'une solution aqueuse comprenant du diethylacetal
WO2019170239A1 (en) *	2018-03-08	2019-09-12	Phytoitalia Srl	Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
IL262050B (en) *	2018-10-02	2020-04-30	Unv Medicine Ltd	Compositions comprising cbd for treating hemorrhoids
EP3894036A2 (en)	2018-12-11	2021-10-20	NATURALIA INGREDIENTS S.r.l	Extraction method and composition obtained therefrom
CN109363975A (zh) *	2018-12-17	2019-02-22	广州诗美化妆品有限公司	一种化妆品用乳香提取物的制备方法与应用
KR102603568B1 (ko) *	2023-03-30	2023-11-20	주식회사 프롬바이오	수용화 매스틱 검을 이용한 피부장벽 기능 개선용 조성물
KR102697519B1 (ko) *	2023-12-05	2024-08-22	주식회사 프롬바이오	수용화 매스틱 검을 이용한 지방 유래 줄기세포의 모유두세포로의 분화 유도용 조성물
KR102705575B1 (ko) *	2023-12-05	2024-09-11	주식회사 프롬바이오	수용화 매스틱 검을 이용한 지방 유래 줄기세포의 섬유아세포로의 분화 유도용 조성물

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4713243A (en)	1986-06-16	1987-12-15	Johnson & Johnson Products, Inc.	Bioadhesive extruded film for intra-oral drug delivery and process
DE4444288A1 (de)	1994-12-13	1996-06-20	Rainer Dr Med Etzel	Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
US5714007A (en)	1995-06-06	1998-02-03	David Sarnoff Research Center, Inc.	Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
GR950100243A (el)	1995-06-28	1997-02-28	�. ��- �. �� .�.�.	Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων.
DE19646392A1 (de)	1996-11-11	1998-05-14	Lohmann Therapie Syst Lts	Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
WO1999034806A1 (en)	1998-01-08	1999-07-15	The Regents Of The University Of California	KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA)
GR1003541B (el)	1999-05-11	2001-03-07		Αντιμικροβιακη και αντιμυκητιακη δραση του εξαγομενου απο τα κλαδια, φυλλα και καρπο της μαστιχας χιου -pistacia lentiscus var chia-, μαστιχελαιου, για χρηση σε καλλυντικες, φαρμακευτικες και παραφαρμακευτικεσς εφαρμογες καθως και στην παραγωγη οδοντοτσι
GR1003550B (el)	1999-09-22	2001-03-13		Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων
US6623728B2 (en)	2000-06-30	2003-09-23	Unilever Home & Personal Care Usa Division Of Conopco, Inc.	Cosmetic skin care compositions and containing gum mastic
GR1003868B (el)	2001-02-06	2002-04-19	Lavipharm S.A.	Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους
WO2002064110A2 (en)	2001-02-13	2002-08-22	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Carotenoid-loaded liposomes
US6534548B1 (en)	2001-10-02	2003-03-18	Kimberly-Clark Worldwide, Inc.	Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria
ATE441423T1 (de)	2002-05-01	2009-09-15	Lavipharm Sa	Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen
AU2003234825A1 (en)	2002-05-20	2003-12-02	Toyo Boseki Kabushiki Kaisha	Wrought fiber sheet and filter unit
JP2004083443A (ja) *	2002-08-23	2004-03-18	Hideji Watanabe	マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法
US20050074509A1 (en)	2003-10-02	2005-04-07	Data Medica Padova S.P.A.	Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components
FR2867980B1 (fr) *	2004-03-23	2006-07-14	Pierre Fabre Medicament Sa	Utilisation de l'acide masticadienonique en tant qu'inhibiteur de l'adn polymerase beta
AU2005227328A1 (en)	2004-03-29	2005-10-06	John A. Beutler	Schweinfurthin analogues
WO2005112967A2 (en)	2004-05-19	2005-12-01	Balfour Marketing Corp.	Anticancer activity of chios mastic gum
US20070292445A1 (en)	2004-07-06	2007-12-20	Transpharma Medical Ltd.	Delivery system for transdermal immunization
EP1793832B1 (en)	2004-08-25	2014-07-23	University of Iowa Research	Geranylgeranyl pyrophosphate synthase inhibitors
JP2007135493A (ja) *	2005-11-18	2007-06-07	Health & Health Kk	健康食品
US20070249543A1 (en) *	2006-04-19	2007-10-25	Filiberto Zadini	Dissolution of arterial cholesterol plaques by phytochemical emulsifiers
WO2008024374A2 (en)	2006-08-22	2008-02-28	Jain Mahendra K	Inhibitors of pancreatic phospholipase a2 for altering cholesterol and fat uptake
US20090048205A1 (en) *	2007-08-15	2009-02-19	Colin Meyer	Combination therapy with synthetic triterpenoids and gemcitabine
KR20100031069A (ko)	2008-09-11	2010-03-19	주식회사 엠디코드	매스틱 추출물 및 그 추출방법
BRPI1013223A2 (pt)	2009-03-04	2017-09-26	Regenera Pharma Ltd	usos terapêuticos de frações de goma de mástique
CN105147759A (zh)	2009-03-04	2015-12-16	瑞吉纳拉制药公司	聚合月桂烯的组合物
CA2810472A1 (en) *	2010-09-07	2012-03-15	Regenera Pharma Ltd.	Compositions comprising acidic extracts of mastic gum
US20150246087A1 (en) *	2012-06-11	2015-09-03	Regenera Pharma Ltd.	Extracts and therapeutic uses thereof

2011
- 2011-09-07 CA CA2810472A patent/CA2810472A1/en not_active Abandoned
- 2011-09-07 CN CN201710169312.9A patent/CN106924266A/zh active Pending
- 2011-09-07 WO PCT/IL2011/000724 patent/WO2012032523A2/en not_active Ceased
- 2011-09-07 AU AU2011300359A patent/AU2011300359B2/en not_active Ceased
- 2011-09-07 BR BR112013005300-3A patent/BR112013005300B1/pt not_active IP Right Cessation
- 2011-09-07 ES ES11823157T patent/ES2732559T3/es active Active
- 2011-09-07 EP EP11823157.0A patent/EP2613777B1/en not_active Not-in-force
- 2011-09-07 PL PL11823157T patent/PL2613777T3/pl unknown
- 2011-09-07 KR KR1020187018478A patent/KR101910781B1/ko not_active Expired - Fee Related
- 2011-09-07 EP EP19159916.6A patent/EP3581177A3/en not_active Withdrawn
- 2011-09-07 BR BR122019022461-7A patent/BR122019022461B1/pt active IP Right Grant
- 2011-09-07 JP JP2013527736A patent/JP5876052B2/ja not_active Expired - Fee Related
- 2011-09-07 US US13/821,194 patent/US9271949B2/en not_active Expired - Fee Related
- 2011-09-07 KR KR1020137008841A patent/KR101875984B1/ko not_active Expired - Fee Related
- 2011-09-07 CN CN201180049685.3A patent/CN103167871B/zh not_active Expired - Fee Related
- 2011-09-07 DK DK11823157.0T patent/DK2613777T3/da active
2013
- 2013-02-28 IL IL225004A patent/IL225004B/en active IP Right Grant
2016
- 2016-01-19 US US15/000,849 patent/US9770456B2/en not_active Expired - Fee Related
- 2016-01-20 JP JP2016009117A patent/JP6097420B2/ja not_active Expired - Fee Related
2017
- 2017-02-17 JP JP2017028225A patent/JP6314265B2/ja not_active Expired - Fee Related
- 2017-08-15 US US15/677,365 patent/US10159680B2/en active Active
2018
- 2018-01-11 IL IL256881A patent/IL256881A/en unknown
- 2018-11-14 US US16/190,780 patent/US10561670B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BR112013005300B1 (pt)	2021-11-09
AU2011300359A1 (en)	2013-04-11
WO2012032523A9 (en)	2012-05-03
ES2732559T3 (es)	2019-11-25
US9770456B2 (en)	2017-09-26
KR20140037006A (ko)	2014-03-26
EP2613777B1 (en)	2019-05-01
EP3581177A3 (en)	2020-02-26
IL256881A (en)	2018-03-29
US20130172416A1 (en)	2013-07-04
JP2017114893A (ja)	2017-06-29
EP2613777A4 (en)	2015-08-12
EP3581177A2 (en)	2019-12-18
JP2016121166A (ja)	2016-07-07
US10159680B2 (en)	2018-12-25
US20170368076A1 (en)	2017-12-28
US9271949B2 (en)	2016-03-01
US20190076444A1 (en)	2019-03-14
US20160199389A1 (en)	2016-07-14
IL225004B (en)	2018-01-31
JP6314265B2 (ja)	2018-04-18
CN103167871B (zh)	2017-06-09
WO2012032523A3 (en)	2012-07-05
CA2810472A1 (en)	2012-03-15
AU2011300359B2 (en)	2014-03-06
EP2613777A2 (en)	2013-07-17
JP2013536877A (ja)	2013-09-26
JP6097420B2 (ja)	2017-03-15
KR101910781B1 (ko)	2018-10-22
WO2012032523A2 (en)	2012-03-15
CN106924266A (zh)	2017-07-07
BR112013005300A2 (pt)	2016-08-16
US10561670B2 (en)	2020-02-18
DK2613777T3 (da)	2019-07-01
KR20180080345A (ko)	2018-07-11
KR101875984B1 (ko)	2018-07-06
CN103167871A (zh)	2013-06-19
BR122019022461B1 (pt)	2022-03-15
JP5876052B2 (ja)	2016-03-02

Publication	Publication Date	Title
IL256881A (en)	2018-03-29	Preparations containing acidic extracts of gum resin
HRP20171343T1 (hr)	2017-12-29	Mješavine
ZA201300458B (en)	2013-09-25	C-met-modulator pharmaceutical compositions
GB201009549D0 (en)	2010-07-21	Compositions
ZA201301766B (en)	2016-11-30	Pharmaceutical compositions
ZA201207670B (en)	2013-05-29	Pharmaceutical compositions
IL214923A (en)	2016-10-31	Compounds containing isolated sections of the gum goddess
ZA201300718B (en)	2013-08-28	Pharmaceutical compositions
GB201009546D0 (en)	2010-07-21	Compositions
PL2385029T3 (pl)	2017-03-31	Kompozycje i sposób cementowania odwiertów
GB201010954D0 (en)	2010-08-11	Compositions
IL221212A0 (en)	2012-10-31	Ethanol compositions
ZA201303223B (en)	2014-01-29	Pharmaceutical compositions
EP2625231A4 (en)	2014-04-16	INK PRESERVATIVE COMPOSITIONS
GB201002861D0 (en)	2010-04-07	Compositions
ZA201303177B (en)	2018-12-19	Pharmaceutical compositions
GB201014591D0 (en)	2010-10-13	Compositions
ZA201304087B (en)	2016-01-27	Oral compositions
LT2654770T (lt)	2018-09-10	Tenekteplazės farmacinės kompozicijos
GB201007790D0 (en)	2010-06-23	Compositions
EP2560678A4 (en)	2013-09-18	PHARMACEUTICAL COMPOSITIONS
GB201019606D0 (en)	2010-12-29	Compositions
GB201008043D0 (en)	2010-06-30	Compositions
ZA201303732B (en)	2018-12-19	Pharmaceutical compositions
GB201008369D0 (en)	2010-07-07	Compositions